This company listing is no longer active
GA1B Stock Overview
Eden Empire Inc. invests in and operates in the cannabis sector.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Eden Empire Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.001 |
| 52 Week High | US$0.004 |
| 52 Week Low | US$0.001 |
| Beta | 0.18 |
| 1 Month Change | -66.67% |
| 3 Month Change | -66.67% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -97.06% |
Recent News & Updates
Recent updates
Shareholder Returns
| GA1B | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | 0% | -4.2% | -1.7% |
| 1Y | n/a | -32.1% | -0.2% |
Return vs Industry: Insufficient data to determine how GA1B performed against the German Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how GA1B performed against the German Market.
Price Volatility
| GA1B volatility | |
|---|---|
| GA1B Average Weekly Movement | 40.4% |
| Pharmaceuticals Industry Average Movement | 6.9% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: GA1B's share price has been volatile over the past 3 months.
Volatility Over Time: GA1B's weekly volatility has increased from 26% to 40% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | David Gdanski | myeden.ca |
Eden Empire Inc. invests in and operates in the cannabis sector. It engages in the retail sale of cannabis in Canada and the United States. Eden Empire Inc. is based in Vancouver, Canada.
Eden Empire Inc. Fundamentals Summary
| GA1B fundamental statistics | |
|---|---|
| Market cap | €138.19k |
| Earnings (TTM) | -€4.98m |
| Revenue (TTM) | €290.04k |
0.0x
P/S Ratio0.0x
P/E RatioIs GA1B overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GA1B income statement (TTM) | |
|---|---|
| Revenue | CA$290.04k |
| Cost of Revenue | CA$476.26k |
| Gross Profit | -CA$186.22k |
| Other Expenses | CA$4.79m |
| Earnings | -CA$4.98m |
Last Reported Earnings
Apr 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.036 |
| Gross Margin | -64.21% |
| Net Profit Margin | -1,716.85% |
| Debt/Equity Ratio | -85.7% |
How did GA1B perform over the long term?
See historical performance and comparison